BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:VX-993 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of VX-993\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06619860-8820@assetmemo.bio
DTSTAMP:20261121T004519Z
DTSTART;VALUE=DATE:20270325
DTEND;VALUE=DATE:20270326
SUMMARY:VX-993: Phase 2 readout est. (NCT06619860)
DESCRIPTION:VX-993\, phase 2\, Diabetic Peripheral Neuropathic Pain.\nStudy
 : Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Dia
 betic Peripheral Neuropathy\nEstimated primary completion: 25 March 2027. 
 This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and
  it can move.\nDrug page: https://assetmemo.bio/drug/vx-993#upcoming-event
 s\nRegistry record: https://clinicaltrials.gov/study/NCT06619860
URL:https://assetmemo.bio/drug/vx-993#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
